Who Paid My Doc
Carlos Montalvan Miro
Nuclear Imaging & Therapy San Juan, PR Medical Doctor
NPI 1033391883 CMS profile 1161532
435 Ponce De Leon Ave, Pavia Hospital, San Juan, PR 00917
General payments
$44
Research payments
$0
Ownership & investment interest
$0
Through program year 2019, Carlos Montalvan Miro of San Juan, PR is reported in the CMS Open Payments database as having received $44 across 3 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2019 | General | $44 | 3 |
Beside peers
- Carlos Montalvan Miro
- Nuclear Imaging & Therapy median
- Middle half of Nuclear Imaging & Therapy
- National median
In program year 2025, general payments to Carlos Montalvan Miro were reported at $0. Among 36 Nuclear Imaging & Therapy profiles paid that year, the median was $122 and the middle half received between $44 and $626.
Show as a table
| Year | Carlos Montalvan Miro | Nuclear Imaging & Therapy median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $44 | $125 | $75–$435 | $163 |
| 2020 | $0 | $115 | $38–$1,233 | $114 |
| 2021 | $0 | $62 | $16–$343 | $132 |
| 2022 | $0 | $123 | $47–$287 | $149 |
| 2023 | $0 | $106 | $56–$169 | $160 |
| 2024 | $0 | $62 | $21–$161 | $164 |
| 2025 | $0 | $122 | $44–$626 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 14 billing codesPaid by Medicare
$1,278
Medicare patients
28
Services billed
36
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 57% | |
| Chronic kidney disease | 46% | |
| Arthritis | 43% | |
| Ischemic heart disease | 39% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
3 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nuclear Imaging & Therapy in Puerto Rico
Cesar Borri Sola
Nuclear Imaging & Therapy · Bayamon, PR
Rene Baez
Nuclear Imaging & Therapy · Ponce, PR
Jorge Toro
Nuclear Imaging & Therapy · San Juan, PR
Ricardo Sein Najera
Nuclear Imaging & Therapy · San Juan, PR
Reinaldo Laguna Figueroa
Nuclear Imaging & Therapy · Santurce, PR
Roberto Annexy Marquez
Nuclear Imaging & Therapy · San Juan, PR
Related records
Nuclear Imaging & Therapy in Puerto Rico
Practitioners in the same specialty and state, ranked by reported value.
All Nuclear Imaging & Therapy
Everyone recorded under this specialty, nationwide.
Doctors in Puerto Rico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.